Latest

2 stories

Hide weekly roundups

Wednesday, September 9

Regulatory decisionAspire Biopharma Holdings, Inc.

Aspire-Lakewood Holdings authorizes $10 million stock buyback, completes name change

The company, formerly Aspire Biopharma Holdings, cited automotive subsidiary DCSC's revenue as support for the expanded repurchase program effective September 9, 2026.

SEC filing

Monday, August 10

M&AAspire Biopharma Holdings, Inc.

Aspire Biopharma closes $30 million acquisition of Dura Driver Control Systems

The pharma-technology company completed its purchase of automotive supplier Dura Driver Control Systems on August 6, 2026, adding over $200 million in reported 2025 revenue.

SEC filing